These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12597262)

  • 41. Effect of soy protein-containing isoflavones on lipoproteins in postmenopausal women.
    Allen JK; Becker DM; Kwiterovich PO; Lindenstruth KA; Curtis C
    Menopause; 2007; 14(1):106-14. PubMed ID: 17019375
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Soy isoflavone supplementation and fasting serum glucose and lipid profile among postmenopausal Chinese women: a double-blind, randomized, placebo-controlled trial.
    Ho SC; Chen YM; Ho SS; Woo JL
    Menopause; 2007; 14(5):905-12. PubMed ID: 17413839
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of high- and low-isoflavone soyfoods on blood lipids, oxidized LDL, homocysteine, and blood pressure in hyperlipidemic men and women.
    Jenkins DJ; Kendall CW; Jackson CJ; Connelly PW; Parker T; Faulkner D; Vidgen E; Cunnane SC; Leiter LA; Josse RG
    Am J Clin Nutr; 2002 Aug; 76(2):365-72. PubMed ID: 12145008
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of isoflavones in the hypocholesterolemic effect of soy.
    Demonty I; Lamarche B; Jones PJ
    Nutr Rev; 2003 Jun; 61(6 Pt 1):189-203. PubMed ID: 12903829
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Soy protein and cardiovascular disease: the impact of bioactive components in soy.
    Potter SM
    Nutr Rev; 1998 Aug; 56(8):231-5. PubMed ID: 9735676
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Soy protein effects on serum lipoproteins: a quality assessment and meta-analysis of randomized, controlled studies.
    Anderson JW; Bush HM
    J Am Coll Nutr; 2011 Apr; 30(2):79-91. PubMed ID: 21730216
    [TBL] [Abstract][Full Text] [Related]  

  • 47. One-year soy protein supplementation does not improve lipid profile in postmenopausal women.
    Campbell SC; Khalil DA; Payton ME; Arjmandi BH
    Menopause; 2010; 17(3):587-93. PubMed ID: 20215976
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Regulation of lipid metabolism by soy protein and its implication in diseases mediated by lipid disorders.
    Torres N; Torre-Villalvazo I; Tovar AR
    J Nutr Biochem; 2006 Jun; 17(6):365-73. PubMed ID: 16481155
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Beneficial effects of a soy-based dietary supplement on lipid levels and cardiovascular risk markers in type 2 diabetic subjects.
    Hermansen K; Søndergaard M; Høie L; Carstensen M; Brock B
    Diabetes Care; 2001 Feb; 24(2):228-33. PubMed ID: 11213870
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of soy protein in cholesterol-lowering: how good is it?
    Nestel P
    Arterioscler Thromb Vasc Biol; 2002 Nov; 22(11):1743-4. PubMed ID: 12426196
    [No Abstract]   [Full Text] [Related]  

  • 51. Effect of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women: a randomized controlled trial.
    Kreijkamp-Kaspers S; Kok L; Grobbee DE; de Haan EH; Aleman A; Lampe JW; van der Schouw YT
    JAMA; 2004 Jul; 292(1):65-74. PubMed ID: 15238592
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of dietary soy protein in obesity.
    Velasquez MT; Bhathena SJ
    Int J Med Sci; 2007 Feb; 4(2):72-82. PubMed ID: 17396158
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dietary soy protein benefit in experimental kidney disease is preserved after isoflavone depletion of diet.
    Ogborn MR; Nitschmann E; Bankovic-Calic N; Weiler HA; Aukema HM
    Exp Biol Med (Maywood); 2010 Nov; 235(11):1315-20. PubMed ID: 20921276
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lipoprotein(a) and dietary proteins: casein lowers lipoprotein(a) concentrations as compared with soy protein.
    Nilausen K; Meinertz H
    Am J Clin Nutr; 1999 Mar; 69(3):419-25. PubMed ID: 10075325
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of soy bean on serum paraoxonase 1 activity and lipoproteins in hyperlipidemic postmenopausal women.
    Shidfar F; Ehramphosh E; Heydari I; Haghighi L; Hosseini S; Shidfar S
    Int J Food Sci Nutr; 2009 May; 60(3):195-205. PubMed ID: 18608549
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of soy or milk protein during a high-fat feeding challenge on oxidative stress, inflammation, and lipids in healthy men.
    Campbell CG; Brown BD; Dufner D; Thorland WG
    Lipids; 2006 Mar; 41(3):257-65. PubMed ID: 16711600
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Soy isoflavones and cardiovascular disease epidemiological, clinical and -omics perspectives.
    Gil-Izquierdo A; Penalvo JL; Gil JI; Medina S; Horcajada MN; Lafay S; Silberberg M; Llorach R; Zafrilla P; Garcia-Mora P; Ferreres F
    Curr Pharm Biotechnol; 2012 Apr; 13(5):624-31. PubMed ID: 22122477
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of a GFOD2 variant on responses in total and LDL cholesterol in Mexican subjects with hypercholesterolemia after soy protein and soluble fiber supplementation.
    Guevara-Cruz M; Lai CQ; Richardson K; Parnell LD; Lee YC; Tovar AR; Ordovás JM; Torres N
    Gene; 2013 Dec; 532(2):211-5. PubMed ID: 24064143
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cardiovascular consequences of life-long exposure to dietary isoflavones in the rat.
    Douglas G; Armitage JA; Taylor PD; Lawson JR; Mann GE; Poston L
    J Physiol; 2006 Mar; 571(Pt 2):477-87. PubMed ID: 16410278
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ethanol-extracted soy protein isolate does not modulate serum cholesterol in golden Syrian hamsters: a model of postmenopausal hypercholesterolemia.
    Lucas EA; Khalil DA; Daggy BP; Arjmandi BH
    J Nutr; 2001 Feb; 131(2):211-4. PubMed ID: 11160535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.